Topics

Genetic Testing, PARP Inhibitors Lead to Transformed Pancreatic Cancer Paradigm

14:15 EST 14 Feb 2020 | OncLive

Eileen O’Reilly, MD, reflects on the treatment advances that are expanding the pancreatic cancer paradigm.

Original Article: Genetic Testing, PARP Inhibitors Lead to Transformed Pancreatic Cancer Paradigm

NEXT ARTICLE

More From BioPortfolio on "Genetic Testing, PARP Inhibitors Lead to Transformed Pancreatic Cancer Paradigm"

Quick Search

Relevant Topics

Pancreatic Cancer
The pancreas secretes a number of important hormones into the digestive tract and the blood stream. Cancers are most commonly exocrine than endocrine (neuroendocrine) tumors. Functional tumors secrete hormones; Insulinoma, Gastrinoma, Somatostatinoma, VI...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...